Market Overview

UPDATE: Credit Suisse Initiates National-Oilwell at Neutral on Limited Upside to Valuation

Share:
Related NOV
Novo Nordisk Completes Phase 3a Trials Comparing Faster-Acting Insulin, Both Trials Achieved Primary Objectives, Treatment Non-Inferior To Novorapid
BMO Capital Initiates Coverage Across Energy Sector
Weekly Guru Bargains Highlights: SBUX, EC, FCX, NOV, PBR.A (GuruFocus)

Credit Suisse initiated coverage on National-Oilwell (NYSE: NOV) with a Neutral rating and a $72.00 price target.

Credit Suisse noted, "NOV Is a Great Company: And it truly is one company, which is impressive considering its origins and history. Since 2004, the company's market cap is up 1100%, which is twice the growth of the nearest rivals, both of which are equipment manufacturers as well. If ever our industry truly had a 900-lb. gorilla, this is it. But while great companies can stay great and get better over time, their share prices are much more volatile, with factors outside of management influence causing fluctuations in valuation, with the latest raising concerns about long-term organic growth."

National-Oilwell closed at $74.14 on Thursday.

Latest Ratings for NOV

DateFirmActionFromTo
Feb 2015BMO CapitalInitiates Coverage onUnderperform
Feb 2015Sterne AgeeDowngradesBuyNeutral
Feb 2015SusquehannaDowngradesPositiveNeutral

View More Analyst Ratings for NOV
View the Latest Analyst Ratings

Posted-In: Credit SuisseAnalyst Color Initiation Analyst Ratings

 

Related Articles (NOV)

Around the Web, We're Loving...